Global Information
회사소개 | 문의 | 비교리스트

세계의 주사용 피부 충전제(스킨 필러) 시장(2022년)

Global Injectable Skin Fillers Market Research Report 2022

리서치사 QYResearch
발행일 2022년 07월 상품코드 1104931
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 2,900 ₩ 3,825,000 PDF (Single User License)
US $ 4,350 ₩ 5,738,000 PDF (Multi User License)
US $ 5,800 ₩ 7,650,000 PDF (Enterprise User License)


세계의 주사용 피부 충전제(스킨 필러) 시장(2022년) Global Injectable Skin Fillers Market Research Report 2022
발행일 : 2022년 07월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19의 대유행에 의해 세계의 주사용 피부 충전제(스킨 필러) 시장 규모는 2022년에 59억 9,268만 달러로 추정되며, 2028년까지 121억 9,013만 달러로 재조정되고, 2022-2028년 예측기간에 CAGR로 12.56%의 성장이 예측됩니다.

이 건강 위기에 의한 경제 변화를 충분히 고려하면, 2021년에 주사용 피부 충전제(스킨 필러) 세계 시장의 73.79%를 차지하고 있는 히알루론산은 2028년까지 91억 5,026만 달러에 달하고, 2022-2028년간 CAGR로 개정 12.86%의 성장이 전망됩니다.

세계의 주사용 피부 충전제(스킨 필러) 주요 제조업체로 Allergan, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma GmbH, Beijing IMEIK, Bloomage BioTechnology 등을 들 수 있습니다. 매출 면에서는 2021년 주사용 피부 충전제(스킨 필러) 시장 점유율은 세계 5대 기업이 71.84%를 차지하고 있습니다.

목차

제1장 주사용 피부 충전제(스킨 필러) 시장 개요

  • 주사용 피부 충전제(스킨 필러) 제품 개요와 범위
  • 주사용 피부 충전제(스킨 필러) 부문 : 종류별
    • 세계의 주사용 피부 충전제(스킨 필러) 판매 성장률 비교 : 종류별(2022-2028년)
    • 히알루론산
    • 콜라겐
    • CaHA
    • 기타
  • 주사용 피부 충전제(스킨 필러) 부문 : 용도별
    • 세계의 주사용 피부 충전제(스킨 필러) 판매 비교 : 용도별(2022-2028년)
    • 전문의·피부과 클리닉
    • 병원·클리닉
    • 기타
  • 세계의 주사용 피부 충전제(스킨 필러) 시장 규모 추정과 예측

제2장 주사용 피부 충전제(스킨 필러) 시장 경쟁 : 제조업체별

  • 세계의 주사용 피부 충전제(스킨 필러) 판매 시장 점유율 : 제조업체별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 매출 시장 점유율 : 제조업체별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 평균 가격 : 제조업체별(2017-2022년)
  • 주사용 피부 충전제(스킨 필러) 제조업체의 제조 거점, 제공 지역, 제품 종류
  • 주사용 피부 충전제(스킨 필러) 시장 경쟁 상황과 동향
  • 제조업체 M&A, 확장 계획

제3장 주사용 피부 충전제(스킨 필러) 소급적 시장 시나리오 : 지역별

  • 세계의 주사용 피부 충전제(스킨 필러) 소급적 시장 시나리오 - 판매 : 지역별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 소급적 시장 시나리오 - 매출 : 지역별(2017-2022년)
  • 북미의 주사용 피부 충전제(스킨 필러) 시장 팩트·수치 : 국가별
  • 유럽의 주사용 피부 충전제(스킨 필러) 시장 팩트·수치 : 국가별
  • 아시아태평양의 주사용 피부 충전제(스킨 필러) 시장 팩트·수치 : 지역별
  • 남미의 주사용 피부 충전제(스킨 필러) 시장 팩트·수치 : 국가별
  • 중동 및 아프리카의 주사용 피부 충전제(스킨 필러) 시장 팩트·수치 : 국가별

제4장 주사용 피부 충전제(스킨 필러) 과거 시장 분석 : 종류별

  • 세계의 주사용 피부 충전제(스킨 필러) 판매 시장 점유율 : 종류별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 매출 시장 점유율 : 종류별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 가격 : 종류별(2017-2022년)

제5장 주사용 피부 충전제(스킨 필러) 과거 시장 분석 : 용도별

  • 세계의 주사용 피부 충전제(스킨 필러) 판매 시장 점유율 : 용도별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 매출 시장 점유율 : 용도별(2017-2022년)
  • 세계의 주사용 피부 충전제(스킨 필러) 가격 : 용도별(2017-2022년)

제6장 주요 기업 개요

  • ABBVIE
  • GALDERMA
  • LG LIFE SCIENCES
  • MERZ
  • MEDYTOX
  • HUGEL
  • CROMA-PHARMA GMBH
  • BEIJING IMEIK
  • BLOOMAGE BIOTECHNOLOGY
  • ELRAVIE(HUMEDIX)
  • CLEVIEL(PHARMA RESEARCH PRODUCTS)
  • HAOHAI BIOLOGICAL TECHNOLOGY
  • Q.O.FILL(JW PHARMACEUTICAL)
  • TEOXANE
  • SINCLAIR
  • SUNEVA MEDICAL
  • CG BIO
  • SCIVISION BIOTECH
  • PROLLENIUM
  • MATEX-LAB
  • JINGJIA MEDICAL TECHNOLOGY
  • GENOSS
  • BOHUS BIOTECH
  • CAREGEN

제7장 주사용 피부 충전제(스킨 필러) 제조 비용 분석

  • 주사용 피부 충전제(스킨 필러) 주요 원재료 분석
  • 제조 비용 구조의 비율
  • 주사용 피부 충전제(스킨 필러) 제조 공정 분석
  • 주사용 피부 충전제(스킨 필러) 업계 체인 분석

제8장 마케팅 채널, 유통업체, 고객

  • 마케팅 채널
  • 주사용 피부 충전제(스킨 필러) 유통업체 리스트
  • 주사용 피부 충전제(스킨 필러) 고객

제9장 주사용 피부 충전제(스킨 필러) 시장 역학

  • 주사용 피부 충전제(스킨 필러) 업계 동향
  • 주사용 피부 충전제(스킨 필러) 시장 성장 촉진요인
  • 주사용 피부 충전제(스킨 필러) 시장 과제·성장 억제요인

제10장 세계 시장 예측

  • 주사용 피부 충전제(스킨 필러) 시장 추정과 예측 : 종류별
  • 주사용 피부 충전제(스킨 필러) 시장 추정과 예측 : 용도별
  • 주사용 피부 충전제(스킨 필러) 시장 추정과 예측 : 지역별

제11장 조사 결과와 결론

제12장 조사 방법과 정보 출처

KSM 22.08.05

LIST OF TABLES

  • Table 1. Global Injectable Skin Fillers Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
  • Table 2. Global Injectable Skin Fillers Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
  • Table 3. Global Injectable Skin Fillers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 4. Global Injectable Skin Fillers Market Competitive Situation by Manufacturers in 2021
  • Table 5. Global Injectable Skin Fillers Sales (K Units) of Key Manufacturers (2017-2022)
  • Table 6. Global Injectable Skin Fillers Sales Market Share by Manufacturers (2017-2022)
  • Table 7. Global Injectable Skin Fillers Revenue (US$ Million) by Manufacturers (2017-2022)
  • Table 8. Global Injectable Skin Fillers Revenue Share by Manufacturers (2017-2022)
  • Table 9. Global Market Injectable Skin Fillers Average Price (USD/Unit) of Key Manufacturers (2017-2022)
  • Table 10. Manufacturers Injectable Skin Fillers Manufacturing Sites and Area Served
  • Table 11. Manufacturers Injectable Skin Fillers Product Type
  • Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 13. Global Injectable Skin Fillers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Skin Fillers as of 2021)
  • Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 15. Global Injectable Skin Fillers Sales by Region (2017-2022) & (K Units)
  • Table 16. Global Injectable Skin Fillers Sales Market Share by Region (2017-2022)
  • Table 17. Global Injectable Skin Fillers Revenue by Region (2017-2022) & (US$ Million)
  • Table 18. Global Injectable Skin Fillers Revenue Market Share by Region (2017-2022)
  • Table 19. North America Injectable Skin Fillers Sales by Country (2017-2022) & (K Units)
  • Table 20. North America Injectable Skin Fillers Sales Market Share by Country (2017-2022)
  • Table 21. North America Injectable Skin Fillers Revenue by Country (2017-2022) & (US$ Million)
  • Table 22. North America Injectable Skin Fillers Revenue Market Share by Country (2017-2022)
  • Table 23. Europe Injectable Skin Fillers Sales by Country (2017-2022) & (K Units)
  • Table 24. Europe Injectable Skin Fillers Sales Market Share by Country (2017-2022)
  • Table 25. Europe Injectable Skin Fillers Revenue by Country (2017-2022) & (US$ Million)
  • Table 26. Europe Injectable Skin Fillers Revenue Market Share by Country (2017-2022)
  • Table 27. Asia Pacific Injectable Skin Fillers Sales by Region (2017-2022) & (K Units)
  • Table 28. Asia Pacific Injectable Skin Fillers Sales Market Share by Region (2017-2022)
  • Table 29. Asia Pacific Injectable Skin Fillers Revenue by Region (2017-2022) & (US$ Million)
  • Table 30. Asia Pacific Injectable Skin Fillers Revenue Market Share by Region (2017-2022)
  • Table 31. South America Injectable Skin Fillers Sales by Country (2017-2022) & (K Units)
  • Table 32. South America Injectable Skin Fillers Sales Market Share by Country (2017-2022)
  • Table 33. South America Injectable Skin Fillers Revenue by Country (2017-2022) & (US$ Million)
  • Table 34. South America Injectable Skin Fillers Revenue Market Share by Country (2017-2022)
  • Table 35. Middle East and Africa Injectable Skin Fillers Sales by Country (2017-2022) & (K Units)
  • Table 36. Middle East and Africa Injectable Skin Fillers Sales Market Share by Country (2017-2022)
  • Table 37. Middle East and Africa Injectable Skin Fillers Revenue by Country (2017-2022) & (US$ Million)
  • Table 38. Middle East and Africa Injectable Skin Fillers Revenue Market Share by Country (2017-2022)
  • Table 39. Global Injectable Skin Fillers Sales by Type (2017-2022) & (K Units)
  • Table 40. Global Injectable Skin Fillers Sales Market Share by Type (2017-2022)
  • Table 41. Global Injectable Skin Fillers Revenue by Type (2017-2022) & (US$ Million)
  • Table 42. Global Injectable Skin Fillers Revenue Share by Type (2017-2022)
  • Table 43. Global Injectable Skin Fillers Price by Type (2017-2022) & (USD/Unit)
  • Table 44. Global Injectable Skin Fillers Sales (K Units) by Application (2017-2022)
  • Table 45. Global Injectable Skin Fillers Sales Market Share by Application (2017-2022)
  • Table 46. Global Injectable Skin Fillers Revenue by Application (2017-2022) & (US$ Million)
  • Table 47. Global Injectable Skin Fillers Revenue Share by Application (2017-2022)
  • Table 48. Global Injectable Skin Fillers Price by Application (2017-2022) & (USD/Unit)
  • Table 49. AbbVie Corporation Information
  • Table 50. AbbVie Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 51. AbbVie Injectable Skin Fillers Product
  • Table 52. AbbVie Recent Developments/Updates
  • Table 53. Galderma Corporation Information
  • Table 54. Galderma Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 55. Galderma Injectable Skin Fillers Product
  • Table 56. Galderma Recent Developments/Updates
  • Table 57. LG Life Sciences Corporation Information
  • Table 58. LG Life Sciences Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 59. LG Life Sciences Injectable Skin Fillers Product
  • Table 60. LG Life Sciences Recent Developments/Updates
  • Table 61. Merz Corporation Information
  • Table 62. Merz Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 63. Merz Injectable Skin Fillers Product
  • Table 64. Merz Recent Developments/Updates
  • Table 65. Medytox Corporation Information
  • Table 66. Medytox Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 67. Medytox Injectable Skin Fillers Product
  • Table 68. Medytox Recent Developments/Updates
  • Table 69. HUGEL Corporation Information
  • Table 70. HUGEL Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 71. HUGEL Injectable Skin Fillers Product
  • Table 72. HUGEL Recent Developments/Updates
  • Table 73. Croma-Pharma GmbH Corporation Information
  • Table 74. Croma-Pharma GmbH Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 75. Croma-Pharma GmbH Injectable Skin Fillers Product
  • Table 76. Croma-Pharma GmbH Recent Developments/Updates
  • Table 77. Beijing IMEIK Corporation Information
  • Table 78. Beijing IMEIK Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 79. Beijing IMEIK Injectable Skin Fillers Product
  • Table 80. Beijing IMEIK Recent Developments/Updates
  • Table 81. Bloomage BioTechnology Corporation Information
  • Table 82. Bloomage BioTechnology Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 83. Bloomage BioTechnology Injectable Skin Fillers Product
  • Table 84. Bloomage BioTechnology Recent Developments/Updates
  • Table 85. Elravie (Humedix) Corporation Information
  • Table 86. Elravie (Humedix) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 87. Elravie (Humedix) Injectable Skin Fillers Product
  • Table 88. Elravie (Humedix) Recent Developments/Updates
  • Table 89. Cleviel (Pharma Research Products) Corporation Information
  • Table 90. Cleviel (Pharma Research Products) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 91. Cleviel (Pharma Research Products) Injectable Skin Fillers Product
  • Table 92. Cleviel (Pharma Research Products) Recent Developments/Updates
  • Table 93. Haohai Biological Technology Corporation Information
  • Table 94. Haohai Biological Technology Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 95. Haohai Biological Technology Injectable Skin Fillers Product
  • Table 96. Haohai Biological Technology Recent Developments/Updates
  • Table 97. Q.O.Fill (JW Pharmaceutical) Corporation Information
  • Table 98. Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 99. Q.O.Fill (JW Pharmaceutical) Injectable Skin Fillers Product
  • Table 100. Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
  • Table 101. Teoxane Corporation Information
  • Table 102. Teoxane Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 103. Teoxane Injectable Skin Fillers Product
  • Table 104. Teoxane Recent Developments/Updates
  • Table 105. Sinclair Corporation Information
  • Table 106. Sinclair Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 107. Sinclair Injectable Skin Fillers Product
  • Table 108. Sinclair Recent Developments/Updates
  • Table 109. Suneva Medical Corporation Information
  • Table 110. Suneva Medical Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 111. Suneva Medical Injectable Skin Fillers Product
  • Table 112. Suneva Medical Recent Developments/Updates
  • Table 113. CG Bio Corporation Information
  • Table 114. CG Bio Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 115. CG Bio Injectable Skin Fillers Product
  • Table 116. CG Bio Recent Developments/Updates
  • Table 117. SciVision Biotech Corporation Information
  • Table 118. SciVision Biotech Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 119. SciVision Biotech Injectable Skin Fillers Product
  • Table 120. SciVision Biotech Recent Developments/Updates
  • Table 121. Prollenium Corporation Information
  • Table 122. Prollenium Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 123. Prollenium Injectable Skin Fillers Product
  • Table 124. Matex-Lab Corporation Information
  • Table 125. Matex-Lab Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 126. Matex-Lab Injectable Skin Fillers Product
  • Table 127. Matex-Lab Recent Developments/Updates
  • Table 128. Jingjia Medical Technology Corporation Information
  • Table 129. Jingjia Medical Technology Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 130. Jingjia Medical Technology Injectable Skin Fillers Product
  • Table 131. Jingjia Medical Technology Recent Developments/Updates
  • Table 132. Genoss Corporation Information
  • Table 133. Genoss Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 134. Genoss Injectable Skin Fillers Product
  • Table 135. Genoss Recent Developments/Updates
  • Table 136. Bohus BioTech Corporation Information
  • Table 137. Bohus BioTech Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 138. Bohus BioTech Injectable Skin Fillers Product
  • Table 139. Caregen Corporation Information
  • Table 140. Caregen Injectable Skin Fillers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 141. Caregen Injectable Skin Fillers Product
  • Table 142. Key Raw Materials Analysis
  • Table 143. Key Suppliers of Raw Materials
  • Table 144. Injectable Skin Fillers Distributors List
  • Table 145. Injectable Skin Fillers Customers List
  • Table 146. Injectable Skin Fillers Market Trends
  • Table 147. Injectable Skin Fillers Market Drivers
  • Table 148. Injectable Skin Fillers Market Challenges and Restraints
  • Table 149. Global Injectable Skin Fillers Sales Forecast by Type (2023-2028) & (K Units)
  • Table 150. Global Injectable Skin Fillers Sales Market Share Forecast by Type (2023-2028)
  • Table 151. Global Injectable Skin Fillers Revenue Forecast by Type (2023-2028) & (US$ Million)
  • Table 152. Global Injectable Skin Fillers Revenue Market Share Forecast by Type (2023-2028)
  • Table 153. Global Injectable Skin Fillers Sales Forecast by Application (2023-2028) & (K Units)
  • Table 154. Global Injectable Skin Fillers Sales Market Share Forecast by Application (2023-2028)
  • Table 155. Global Injectable Skin Fillers Revenue Forecast by Application (2023-2028) & (US$ Million)
  • Table 156. Global Injectable Skin Fillers Revenue Market Share Forecast by Application (2023-2028)
  • Table 157. Global Injectable Skin Fillers Sales Forecast by Region (2023-2028) & (K Units)
  • Table 158. Global Injectable Skin Fillers Sales Market Share Forecast by Region (2023-2028)
  • Table 159. Global Injectable Skin Fillers Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 160. Global Injectable Skin Fillers Revenue Market Share Forecast by Region (2023-2028)
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Injectable Skin Fillers
  • Figure 2. Global Injectable Skin Fillers Market Share by Type: 2022
  • Figure 3. Global Injectable Skin Fillers Market Share by Type: 2028
  • Figure 4. Hyaluronic Acid Product Picture
  • Figure 5. Collagen Product Picture
  • Figure 6. CaHA Product Picture
  • Figure 7. Global Injectable Skin Fillers Market Share by Application: 2022
  • Figure 8. Global Injectable Skin Fillers Market Share by Application: 2028
  • Figure 9. Specialist and Dermatology Clinic
  • Figure 10. Hospitals and Clinics
  • Figure 11. Global Injectable Skin Fillers Revenue, (US$ Million), 2017 VS 2022 VS 2028
  • Figure 12. Global Injectable Skin Fillers Market Size (2017-2028) & (US$ Million)
  • Figure 13. Global Injectable Skin Fillers Sales (2017-2028) & (K Units)
  • Figure 14. Injectable Skin Fillers Sales Share by Manufacturers in 2021
  • Figure 15. Global Injectable Skin Fillers Revenue Share by Manufacturers in 2021
  • Figure 16. Global 5 Largest Injectable Skin Fillers Players: Market Share by Revenue in Injectable Skin Fillers in 2021
  • Figure 17. Global 5 and 10 Largest Injectable Skin Fillers Players: Market Share by Revenue in Injectable Skin Fillers in 2021
  • Figure 18. North America Injectable Skin Fillers Sales Market Share by Country in 2021
  • Figure 19. United States Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 20. Canada Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 21. Mexico Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 22. Germany Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 23. France Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 24. U.K. Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 25. Italy Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 26. Russia Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 27. China Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 28. Japan Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 29. South Korea Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 30. India Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 31. Australia Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 32. Southeast Asia Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 33. Brazil Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 34. Middle East Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 35. Africa Injectable Skin Fillers Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 36. Sales Market Share of Injectable Skin Fillers by Type (2017-2022)
  • Figure 37. Manufacturing Cost Structure of Injectable Skin Fillers
  • Figure 38. Manufacturing Process Analysis of Injectable Skin Fillers
  • Figure 39. Injectable Skin Fillers Industrial Chain Analysis
  • Figure 40. Channels of Distribution
  • Figure 41. Distributors Profiles
  • Figure 42. Bottom-up and Top-down Approaches for This Report
  • Figure 43. Data Triangulation
  • Figure 44. Key Executives Interviewed 115

Due to the COVID-19 pandemic, the global Injectable Skin Fillers market size is estimated to be worth US$ 5992.68 million in 2022 and is forecast to a readjusted size of US$ 12190.13 million by 2028 with a CAGR of 12.56% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Hyaluronic Acid accounting for 73.79% of the Injectable Skin Fillers global market in 2021, is projected to value US$ 9150.26 million by 2028, growing at a revised 12.86% CAGR from 2022 to 2028.

The global major manufacturers of Injectable Skin Fillers include Allergan, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma GmbH, Beijing IMEIK, and Bloomage BioTechnology, etc. In terms of revenue, the global five largest players hold a 71.84% market share of Injectable Skin Fillers in 2021.

This report focuses on Injectable Skin Fillers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Injectable Skin Fillers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, APAC, South America, Middle East and Africa.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • AbbVie
  • Galderma
  • LG Life Sciences
  • Merz
  • Beijing IMEIK
  • Teoxane
  • HUGEL
  • Bloomage Bio
  • Sinclair
  • Elravie (Humedix)
  • Croma-Pharma
  • Cleviel (Pharma Research Products)
  • Medytox
  • Haohai Biological
  • Prollenium
  • Suneva Medical
  • Q.O.Fill (JW Pharmaceutical)
  • SciVision Biotech
  • Matex-Lab
  • CG Bio
  • Caregen
  • Bohus BioTech
  • Genoss
  • Jingjia Medical

Segment by Type

  • Hyaluronic Acid
  • Collagen
  • CaHA
  • Others

Segment by Application

  • Specialist and Dermatology Clinic
  • Hospitals and Clinics
  • Others

Consumption by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Middle East and Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 INJECTABLE SKIN FILLERS MARKET OVERVIEW

  • 1.1 PRODUCT OVERVIEW AND SCOPE OF INJECTABLE SKIN FILLERS
  • 1.2 INJECTABLE SKIN FILLERS SEGMENT BY TYPE
    • 1.2.1 GLOBAL INJECTABLE SKIN FILLERS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028)
    • 1.2.2 HYALURONIC ACID
    • 1.2.3 COLLAGEN
    • 1.2.4 CAHA
    • 1.2.5 OTHERS
  • 1.3 INJECTABLE SKIN FILLERS SEGMENT BY APPLICATION
    • 1.3.1 GLOBAL INJECTABLE SKIN FILLERS SALES COMPARISON BY APPLICATION (2022-2028)
    • 1.3.2 SPECIALIST AND DERMATOLOGY CLINIC
    • 1.3.3 HOSPITALS AND CLINICS
    • 1.3.4 OTHERS
  • 1.4 GLOBAL INJECTABLE SKIN FILLERS MARKET SIZE ESTIMATES AND FORECASTS
    • 1.4.1 GLOBAL INJECTABLE SKIN FILLERS REVENUE 2017-2028
    • 1.4.2 GLOBAL INJECTABLE SKIN FILLERS SALES 2017-2028
    • 1.4.3 INJECTABLE SKIN FILLERS MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028

2 INJECTABLE SKIN FILLERS MARKET COMPETITION BY MANUFACTURERS

  • 2.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY MANUFACTURERS (2017-2022)
  • 2.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022)
  • 2.3 GLOBAL INJECTABLE SKIN FILLERS AVERAGE PRICE BY MANUFACTURERS (2017-2022)
  • 2.4 MANUFACTURERS INJECTABLE SKIN FILLERS MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE
  • 2.5 INJECTABLE SKIN FILLERS MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.5.1 INJECTABLE SKIN FILLERS MARKET CONCENTRATION RATE
    • 2.5.2 THE GLOBAL 5 AND 10 LARGEST INJECTABLE SKIN FILLERS PLAYERS MARKET SHARE BY REVENUE
    • 2.5.3 GLOBAL INJECTABLE SKIN FILLERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
  • 2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS

3 INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 GLOBAL INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022
  • 3.2 GLOBAL INJECTABLE SKIN FILLERS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022
  • 3.3 NORTH AMERICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY
    • 3.3.1 NORTH AMERICA INJECTABLE SKIN FILLERS SALES BY COUNTRY
    • 3.3.2 NORTH AMERICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY
    • 3.3.3 UNITED STATES
    • 3.3.4 CANADA
    • 3.3.5 MEXICO
  • 3.4 EUROPE INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY
    • 3.4.1 EUROPE INJECTABLE SKIN FILLERS SALES BY COUNTRY
    • 3.4.2 EUROPE INJECTABLE SKIN FILLERS REVENUE BY COUNTRY
    • 3.4.3 GERMANY
    • 3.4.4 FRANCE
    • 3.4.5 U.K.
    • 3.4.6 ITALY
    • 3.4.7 RUSSIA
  • 3.5 ASIA PACIFIC INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY REGION
    • 3.5.1 ASIA PACIFIC INJECTABLE SKIN FILLERS SALES BY REGION
    • 3.5.2 ASIA PACIFIC INJECTABLE SKIN FILLERS REVENUE BY REGION
    • 3.5.3 CHINA
    • 3.5.4 JAPAN
    • 3.5.5 SOUTH KOREA
    • 3.5.6 INDIA
    • 3.5.7 AUSTRALIA
    • 3.5.8 SOUTHEAST ASIA
  • 3.6 SOUTH AMERICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY
    • 3.6.1 SOUTH AMERICA INJECTABLE SKIN FILLERS SALES BY COUNTRY
    • 3.6.2 SOUTH AMERICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY
    • 3.6.3 BRAZIL
  • 3.7 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS MARKET FACTS & FIGURES BY COUNTRY
    • 3.7.1 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS SALES BY COUNTRY
    • 3.7.2 MIDDLE EAST AND AFRICA INJECTABLE SKIN FILLERS REVENUE BY COUNTRY
    • 3.7.3 MIDDLE EAST
    • 3.7.4 AFRICA

4 INJECTABLE SKIN FILLERS HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY TYPE (2017-2022)
  • 4.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY TYPE (2017-2022)
  • 4.3 GLOBAL INJECTABLE SKIN FILLERS PRICE BY TYPE (2017-2022)

5 INJECTABLE SKIN FILLERS HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 GLOBAL INJECTABLE SKIN FILLERS SALES MARKET SHARE BY APPLICATION (2017-2022)
  • 5.2 GLOBAL INJECTABLE SKIN FILLERS REVENUE MARKET SHARE BY APPLICATION (2017-2022)
  • 5.3 GLOBAL INJECTABLE SKIN FILLERS PRICE BY APPLICATION (2017-2022)

6 KEY COMPANIES PROFILED

  • 6.1 ABBVIE
    • 6.1.1 ABBVIE CORPORATION INFORMATION
    • 6.1.2 ABBVIE INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.1.3 ABBVIE INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.1.4 ABBVIE RECENT DEVELOPMENTS/UPDATES
  • 6.2 GALDERMA
    • 6.2.1 GALDERMA CORPORATION INFORMATION
    • 6.2.2 GALDERMA INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.2.3 GALDERMA INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.2.4 GALDERMA RECENT DEVELOPMENTS/UPDATES
  • 6.3 LG LIFE SCIENCES
    • 6.3.1 LG LIFE SCIENCES CORPORATION INFORMATION
    • 6.3.2 LG LIFE SCIENCES INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.3.3 LG LIFE SCIENCES INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.3.4 LG LIFE SCIENCES RECENT DEVELOPMENTS/UPDATES
  • 6.4 MERZ
    • 6.4.1 MERZ CORPORATION INFORMATION
    • 6.4.2 MERZ INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.4.3 MERZ INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.4.4 MERZ RECENT DEVELOPMENTS/UPDATES
  • 6.5 MEDYTOX
    • 6.5.1 MEDYTOX CORPORATION INFORMATION
    • 6.5.2 MEDYTOX INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.5.3 MEDYTOX INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.5.4 MEDYTOX RECENT DEVELOPMENTS/UPDATES
  • 6.6 HUGEL
    • 6.6.1 HUGEL CORPORATION INFORMATION
    • 6.6.2 HUGEL INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.6.3 HUGEL INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.6.4 HUGEL RECENT DEVELOPMENTS/UPDATES
  • 6.7 CROMA-PHARMA GMBH
    • 6.7.1 CROMA-PHARMA GMBH CORPORATION INFORMATION
    • 6.7.2 CROMA-PHARMA GMBH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.7.3 CROMA-PHARMA GMBH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.7.4 CROMA-PHARMA GMBH RECENT DEVELOPMENTS/UPDATES
  • 6.8 BEIJING IMEIK
    • 6.8.1 BEIJING IMEIK CORPORATION INFORMATION
    • 6.8.2 BEIJING IMEIK INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.8.3 BEIJING IMEIK INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.8.4 BEIJING IMEIK RECENT DEVELOPMENTS/UPDATES
  • 6.9 BLOOMAGE BIOTECHNOLOGY
    • 6.9.1 BLOOMAGE BIOTECHNOLOGY CORPORATION INFORMATION
    • 6.9.2 BLOOMAGE BIOTECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.9.3 BLOOMAGE BIOTECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.9.4 BLOOMAGE BIOTECHNOLOGY RECENT DEVELOPMENTS/UPDATES
  • 6.10 ELRAVIE (HUMEDIX)
    • 6.10.1 ELRAVIE (HUMEDIX) CORPORATION INFORMATION
    • 6.10.2 ELRAVIE (HUMEDIX) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.10.3 ELRAVIE (HUMEDIX) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.10.4 ELRAVIE (HUMEDIX) RECENT DEVELOPMENTS/UPDATES
  • 6.11 CLEVIEL (PHARMA RESEARCH PRODUCTS)
    • 6.11.1 CLEVIEL (PHARMA RESEARCH PRODUCTS) CORPORATION INFORMATION
    • 6.11.2 CLEVIEL (PHARMA RESEARCH PRODUCTS) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.11.3 CLEVIEL (PHARMA RESEARCH PRODUCTS) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.11.4 CLEVIEL (PHARMA RESEARCH PRODUCTS) RECENT DEVELOPMENTS/UPDATES
  • 6.12 HAOHAI BIOLOGICAL TECHNOLOGY
    • 6.12.1 HAOHAI BIOLOGICAL TECHNOLOGY CORPORATION INFORMATION
    • 6.12.2 HAOHAI BIOLOGICAL TECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.12.3 HAOHAI BIOLOGICAL TECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.12.4 HAOHAI BIOLOGICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES
  • 6.13 Q.O.FILL (JW PHARMACEUTICAL)
    • 6.13.1 Q.O.FILL (JW PHARMACEUTICAL) CORPORATION INFORMATION
    • 6.13.2 Q.O.FILL (JW PHARMACEUTICAL) INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.13.3 Q.O.FILL (JW PHARMACEUTICAL) INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.13.4 Q.O.FILL (JW PHARMACEUTICAL) RECENT DEVELOPMENTS/UPDATES
  • 6.14 TEOXANE
    • 6.14.1 TEOXANE CORPORATION INFORMATION
    • 6.14.2 TEOXANE INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.14.3 TEOXANE INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.14.4 TEOXANE RECENT DEVELOPMENTS/UPDATES
  • 6.15 SINCLAIR
    • 6.15.1 SINCLAIR CORPORATION INFORMATION
    • 6.15.2 SINCLAIR INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.15.3 SINCLAIR INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.15.4 SINCLAIR RECENT DEVELOPMENTS/UPDATES
  • 6.16 SUNEVA MEDICAL
    • 6.16.1 SUNEVA MEDICAL CORPORATION INFORMATION
    • 6.16.2 SUNEVA MEDICAL INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.16.3 SUNEVA MEDICAL INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.16.4 SUNEVA MEDICAL RECENT DEVELOPMENTS/UPDATES
  • 6.17 CG BIO
    • 6.17.1 CG BIO CORPORATION INFORMATION
    • 6.17.2 CG BIO INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.17.3 CG BIO INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.17.4 CG BIO RECENT DEVELOPMENTS/UPDATES
  • 6.18 SCIVISION BIOTECH
    • 6.18.1 SCIVISION BIOTECH CORPORATION INFORMATION
    • 6.18.2 SCIVISION BIOTECH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.18.3 SCIVISION BIOTECH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.18.4 SCIVISION BIOTECH RECENT DEVELOPMENTS/UPDATES
  • 6.19 PROLLENIUM
    • 6.19.1 PROLLENIUM CORPORATION INFORMATION
    • 6.19.2 PROLLENIUM INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.19.3 PROLLENIUM INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
  • 6.20 MATEX-LAB
    • 6.20.1 MATEX-LAB CORPORATION INFORMATION
    • 6.20.2 MATEX-LAB INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.20.3 MATEX-LAB INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.20.4 MATEX-LAB RECENT DEVELOPMENTS/UPDATES
  • 6.21 JINGJIA MEDICAL TECHNOLOGY
    • 6.21.1 JINGJIA MEDICAL TECHNOLOGY CORPORATION INFORMATION
    • 6.21.2 JINGJIA MEDICAL TECHNOLOGY INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.21.3 JINGJIA MEDICAL TECHNOLOGY INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.21.4 JINGJIA MEDICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES
  • 6.22 GENOSS
    • 6.22.1 GENOSS CORPORATION INFORMATION
    • 6.22.2 GENOSS INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.22.3 GENOSS INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
    • 6.22.4 GENOSS RECENT DEVELOPMENTS/UPDATES
  • 6.23 BOHUS BIOTECH
    • 6.23.1 BOHUS BIOTECH CORPORATION INFORMATION
    • 6.23.2 BOHUS BIOTECH INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.23.3 BOHUS BIOTECH INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO
  • 6.24 CAREGEN
    • 6.24.1 CAREGEN CORPORATION INFORMATION
    • 6.24.2 CAREGEN INJECTABLE SKIN FILLERS SALES, REVENUE AND GROSS MARGIN (2017-2022)
    • 6.24.3 CAREGEN INJECTABLE SKIN FILLERS PRODUCT PORTFOLIO

7 INJECTABLE SKIN FILLERS MANUFACTURING COST ANALYSIS

  • 7.1 INJECTABLE SKIN FILLERS KEY RAW MATERIALS ANALYSIS
    • 7.1.1 KEY RAW MATERIALS
    • 7.1.2 KEY SUPPLIERS OF RAW MATERIALS
  • 7.2 PROPORTION OF MANUFACTURING COST STRUCTURE
  • 7.3 MANUFACTURING PROCESS ANALYSIS OF INJECTABLE SKIN FILLERS
  • 7.4 INJECTABLE SKIN FILLERS INDUSTRIAL CHAIN ANALYSIS

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 MARKETING CHANNEL
  • 8.2 INJECTABLE SKIN FILLERS DISTRIBUTORS LIST
  • 8.3 INJECTABLE SKIN FILLERS CUSTOMERS

9 INJECTABLE SKIN FILLERS MARKET DYNAMICS

  • 9.1 INJECTABLE SKIN FILLERS INDUSTRY TRENDS
  • 9.2 INJECTABLE SKIN FILLERS MARKET DRIVERS
  • 9.3 INJECTABLE SKIN FILLERS MARKET CHALLENGES AND RESTRAINTS

10 GLOBAL MARKET FORECAST

  • 10.1 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY TYPE
    • 10.1.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY TYPE (2023-2028)
    • 10.1.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY TYPE (2023-2028)
  • 10.2 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION
    • 10.2.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY APPLICATION (2023-2028)
    • 10.2.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY APPLICATION (2023-2028)
  • 10.3 INJECTABLE SKIN FILLERS MARKET ESTIMATES AND PROJECTIONS BY REGION
    • 10.3.1 GLOBAL FORECASTED SALES OF INJECTABLE SKIN FILLERS BY REGION (2023-2028)
    • 10.3.2 GLOBAL FORECASTED REVENUE OF INJECTABLE SKIN FILLERS BY REGION (2023-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 METHODOLOGY/RESEARCH APPROACH
    • 12.1.1 RESEARCH PROGRAMS/DESIGN
    • 12.1.2 MARKET SIZE ESTIMATION
    • 12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 12.2 DATA SOURCE
    • 12.2.1 SECONDARY SOURCES
    • 12.2.2 PRIMARY SOURCES
  • 12.3 AUTHOR LIST
  • 12.4 DISCLAIMER
Back to Top
전화 문의
F A Q